More on MXCT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (6.7 Score)

Upcoming Events

- Earnings (5/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MaxCyte, Inc. (NQ:MXCT)
Delayed: 0.78 -0.06 (7.14%)
Prev. Close $0.84  
Open$0.84 
52 Wk High$ 
52 Wk Low$ 
Day High$0.84 
Day Low$0.76 
P/E N/A  
EPS$ 
Volume1,087,396 

Friends, Peers and Foes (?): MXCN (more...)

Feb 24, 2026 08:05 AM MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
Feb 23, 2026 04:05 PM MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
Feb 17, 2026 02:29 PM Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: CADIAN CAPITAL MANAGEMENT, LP
Feb 5, 2026 08:04 AM Form SCHEDULE 13G MAXCYTE, INC. Filed by: Capricorn Fund Managers Ltd
Jan 21, 2026 12:32 PM Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: BlackRock, Inc.
Jan 12, 2026 04:46 PM Form 8-K MAXCYTE, INC. For: Jan 12
Dec 1, 2025 09:01 AM Cellares names Ali Soleymannezhad as chief commercial officer
Dec 1, 2025 09:00 AM Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO
Nov 14, 2025 01:40 PM Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: CADIAN CAPITAL MANAGEMENT, LP
Nov 13, 2025 04:37 PM Form 10-Q MAXCYTE, INC. For: Sep 30
View All Articles

Entities mentioned with MXCT

View All Entities